Back to Report Store Home

Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 – Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market

  • Published: Dec-2017
  • Report Code: GBIHC465MR
  • Report Format: pdf

Description

List of Figures

Figure 1: HNC Therapeutics Market, Australia, Estimated Age-Specific Incidence and Mortality Rates for HNC, by Sex, 2017 12

Figure 2: HNC Therapeutics Market, Australia, Five-Year Relative Survival from HNC by Sex, 1984–2013 12

Figure 3: HNC Therapeutics Market, Treatment Algorithm for HNC (Excluding Nasopharyngeal and Thyroid Cancer) 32

Figure 4: HNC Therapeutics Market, Treatment Algorithm for Nasopharyngeal Cancer and Thyroid Cancer 33

Figure 5: HNC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products 53

Figure 6: HNC Therapeutics Market, Global, Pipeline, 2017 59

Figure 7: HNC Therapeutics Market, Global, Pipeline by Molecular Target, 2017 61

Figure 8: HNC Therapeutics Market, Pipeline by Molecular Target and Stage of Development, 2017 62

Figure 9: HNC Therapeutics Market, APAC, Imfinzi Forecast ($m), 2019–2023 65

Figure 10: HNC Therapeutics Market, APAC, Durvalumab plus Tremelimumab Forecast ($m), 2019–2023 66

Figure 11: HNC Therapeutics Market, APAC, Gilotrif/Giotrif/Xovoltib Forecast ($m), 2020–2023 68

Figure 12: HNC Therapeutics Market, Comparative Efficacy and Safety Heatmap for Pipeline Products 71

Figure 13: HNC Therapeutics Market, Competitor Matrix for HNC Marketed and Pipeline Products, 2017 72

Figure 14: HNC Therapeutics, Global, Average Clinical Trial Failure Rate (%), 2006–2016 74

Figure 15: HNC Therapeutics, Global, Clinical Trial Failure Rates by Molecule Type (%), 2006–2016 75

Figure 16: HNC Therapeutics, Global, Clinical Trial Failure Rates by Molecular Target (%), 2006–2016 76

Figure 17: HNC Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2006–2016 77

Figure 18: HNC Therapeutics, Global, Clinical Trial Size per Product by Molecular Target (participants), 2006–2016 78

Figure 19: HNC Therapeutics, Global, Clinical Trial Size per Trial by Molecule Type (participants), 2006–2016 79

Figure 20: HNC Therapeutics, Global, Clinical Trial Size per Trial by Molecular Target (participants), 2006–2016 80

Figure 21: HNC Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2006–2016 81

Figure 22: HNC Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2006–2016 82

Figure 23: HNC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecule Type 83

Figure 24: HNC Therapeutics Market, Global, Comparison of Average Trial Metrics by Phase and Molecular Target 83

Figure 25: HNC Therapeutics Market, APAC, Treatment Patterns (‘000), 2016–2023 86

Figure 26: HNC Therapeutics Market, APAC, Market Size ($m), 2016–2023 87

Figure 27: HNC Therapeutics Market, India, Treatment Patterns (‘000), 2016–2023 88

Figure 28: HNC Therapeutics Market, India, Annual Cost of Therapy ($), 2016–2023 89

Figure 29: HNC Therapeutics Market, India, Market Size ($m), 2016–2023 90

Figure 30: HNC Therapeutics Market, China, Treatment Patterns (‘000), 2016–2023 91

Figure 31: HNC Therapeutics Market, China, Annual Cost of Therapy ($), 2016–2023 92

Figure 32: HNC Therapeutics Market, China, Market Size ($m), 2016–2023 93

Figure 33: HNC Therapeutics Market, Australia, Treatment Patterns (‘000), 2016–2023 94

Figure 34: HNC Therapeutics Market, Australia, Annual Cost of Therapy ($), 2016–2023 95

Figure 35: HNC Therapeutics Market, Australia, Market Size ($m), 2016–2023 96

Figure 36: HNC Therapeutics Market, South Korea, Treatment Patterns (‘000), 2016–2023 98

Figure 37: HNC Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2016–2023 99

Figure 38: HNC Therapeutics Market, South Korea, Market Size ($m), 2016–2023 100

Figure 39: HNC Therapeutics Market, Japan, Treatment Patterns (‘000), 2016–2023 101

Figure 40: HNC Therapeutics Market, Japan, Annual Cost of Therapy ($), 2016–2023 102

Figure 41: HNC Therapeutics Market, Japan, Market Size ($m), 2016–2023 103

Figure 42: HNC Therapeutics Market, Global, Licensing Deals by Region and Value, 2006–2017 109

Figure 43: HNC Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Value ($m), 2006–2017 110

Figure 44: HNC Therapeutics Market, Global, Licensing Deals by Stage of Development, Deal Value ($m) and Upfront Payment Value ($m), 2006–2017 111

Figure 45: HNC Therapeutics Market, Global, Licensing Deals by Molecule Type, Stage of Development and Aggregate Deal Value ($m), 2006–2017 112

Figure 46: HNC Therapeutics Market, Global, Licensing Deals by Molecular Target and Aggregate Deal Value ($m), 2006–2017 113

Figure 47: HNC Therapeutics Market, Global, Co-development Deals by Region, 2006–2017 115

Figure 48: HNC Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-development Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Value ($m), 2006–2017 116

Figure 49: HNC Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value ($m) and Upfront Payment Value ($m), 2006–2017 117

Figure 50: HNC Therapeutics Market, Global, Co-development Deals by Molecule Type, Stage of Development and Aggregate Deal Value ($m), 2006–2017 118

Figure 51: HNC Therapeutics Market, Global, Co-development Deals by by Molecular Target and Aggregate Deal Value ($m), 2006–2017 119

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards